In this presentation, Dr. Daly discusses the recent FDA alert regarding biotin supplements interfering with immunoassay testing.  This can cause discrepancies particularly in endocrine testing.  In the face of laboratory immunoassay results that do not appear to reflect a true picture of the patient’s condition, question the patient about use of supplements containing biotin.

Click the image below to view this informative video that runs around 6 minutes.

About The Author

Prior to his role as Chief Medical Officer at COLA, Dr. John Daly was the Director of Clinical Laboratories for the Duke University Health System from 2005-2009. A longtime resident of Durham, NC, Dr. Daly was quite active in the local medical community, joining the staffs of three area hospitals and serving as a member of various hospital committees. He earned his M. D. at Cornell University Medical College, and performed his internship and residency in pathology at Duke University Medical Center. He also is a veteran of the U. S. Navy.

Related Posts

Send this to a friend